Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline : Shingles Vaccine Receives Recommendation in US for Immunocompromised Adults

10/20/2021 | 11:31pm EST


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
12/03Gsk - Preclinical data demonstrate sotrovimab retains activity against key Omicron muta..
AQ
12/03GLAXOSMITHKLINE : Deutsche Bank reaffirms its Neutral rating
MD
12/02Gavi to Fund Supply of GlaxoSmithKline's Malaria Vaccine to Children in Africa
MT
12/02Health Care Ticks Up On Cyclical Bias -- Health Care Roundup
DJ
12/02US Stocks Rebound Following Recent Sell-Offs as Omicron Variant Concerns Subside
MT
12/02GLAXOSMITHKLINE : MHRA grants conditional marketing authorisation1 for COVID-19 treatment ..
PU
12/02Stocks Led Higher Midday by Financials, Energy; GlaxoSmithKline Says Sotrovimab Showed ..
MT
12/02MIDDAY REPORT : US Stocks Led Higher by Financials, Energy; GlaxoSmithKline Says Sotrovima..
MT
12/02GLAXOSMITHKLINE : GSK welcomes Gavi decision to fund the roll out of malaria vaccines for ..
PU
12/02Gsk Says Product Transfer For Malaria Vaccine Underway With Bharat Biotech Of India
RE
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 843 M 44 865 M 44 865 M
Net income 2021 4 028 M 5 339 M 5 339 M
Net Debt 2021 20 702 M 27 444 M 27 444 M
P/E ratio 2021 19,0x
Yield 2021 5,21%
Capitalization 76 852 M 102 B 102 B
EV / Sales 2021 2,88x
EV / Sales 2022 2,72x
Nbr of Employees 94 066
Free-Float 92,3%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 534,60 GBX
Average target price 1 679,64 GBX
Spread / Average Target 9,45%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC14.35%101 616
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641